Results 141 to 150 of about 1,032,633 (361)

Health Inequalities: A Public Health Priority!

open access: yesArthroplasty Today, 2020
Mohamad J. Halawi   +2 more
openaire   +3 more sources

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

open access: yesMolecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci   +6 more
wiley   +1 more source

Carga de cáncer del departamento de Nariño y subregiones, Colombia, 2010

open access: yesRevista Facultad Nacional de Salud Pública, 2014
Resumen Objetivo: medir la carga de cáncer a partir del indicador Años de Vida Saludables Perdidos (avisa) en el Departamento de Nariño y subregiones.
Elizabeth Trujillo-Montalvo   +3 more
doaj  

Academies Capital Maintenance Fund 2013-14: round 1: guidance for applicants [PDF]

open access: yes, 2012
There are two priorities for the fund: 1. Tackling building condition issues including Health and Safety issues that cannot be met from routine maintenance or Devolved Formula Capital funding. - 2.

core  

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren   +16 more
wiley   +1 more source

Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Fibroblasts, cells in the tumor environment, support ovarian cancer cell growth and alter morphology and drug response. We used fibroblast and cancer cell co‐culture models to test 528 drugs and discovered new drugs for combination treatment. We showed that adding Vorinostat or Birinapant to standard chemotherapy may improve drug response, suggesting ...
Greta Gudoityte   +10 more
wiley   +1 more source

Health priorities and the social determinants of health [PDF]

open access: yesEastern Mediterranean Health Journal, 2015
Jessica Allen, Michael Marmot
openaire   +2 more sources

Home - About - Disclaimer - Privacy